Skip to main content

Table 2 Analysis of correlations between CSF-GPNMB and other parameters in study cohort 1

From: Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer’s disease

Correlations

CSF GPNMB

 

Total sample

Controls

AD

Age

0.3738 (< 0.0001)

0.3970 (0.0004)

0.4225 (0.0015)

CSF pTau181

0.2716 (0.0025)

0.1834 (0.1315)

0.3114 (0.0232)

MSD-CSF Aβ38

0.1108 (0.2168)

0.0918 (0.4432)

0.0784 (0.5727)

MSD-CSF Aβ40

0.0860 (0.3381)

0.0894 (0.4552)

0.0359 (0.7964)

MSD-CSF Aβ42

−0.0771 (0.3907)

0.0619 (0.6053)

−0.1257 (0.3649)

MSD-CSF Aβ42/40

−0.2267 (0.0107)

−0.1003 (0.4020)

− 0.3888 (0.0049)

  1. Spearman’s rho (p-value), CSF cerebrospinal fluid